There are 7 papers on platelet to white blood cell ratio in aging research: 7 observational studies in people.
7 papers study it8 findings
“A decreased risk of fatal all stroke showed in those with the highest quartiles for both the PWR (aHR = 0.73, 95% CI 0.53-1.00)”
- Humans7
Associations
7Type 2 diabetes
downin humans1HR 0.76
1 study
Type 2 diabetes
downin humans1HR 0.76
Platelet to white blood cell ratio is linked with a lower risk of type 2 diabetes in humans (highest vs. lowest quartile) (HR 0.760, 95% CI 0.615-0.940, P = 0.011).
“Participants in the highest PWR quartile had a 24.0% lower risk (HR 0.760, 95% CI 0.615-0.940, P = 0.011) compared to the lowest quartile.”
Humanshighest vs. lowest quartilen = 7,571
BMC endocrine disorders
Sarcopenic obesity
downin humans1OR 0.621
1 study
Sarcopenic obesity
downin humans1OR 0.621
Platelet to white blood cell ratio is associated with sarcopenic obesity in humans under waist circumference classification (OR = 0.621, 95% CI: 0.390–0.988).
“but inversely associated with PWR (OR = 0.621, 95% CI: 0.390–0.988; P = 0.040)”
Humansunder waist circumference classificationn = 1,009
Nutrition & metabolism
Total skeletal muscle mass index
downin humans1
1 study
Total skeletal muscle mass index
downin humans1
Platelet to white blood cell ratio is associated with total skeletal muscle mass index in humans (multivariate linear regression) (beta = -0.0051 (95% CI: -0.0102 to -0.0001)).
“PWR were associated with low TSMI, with coefficients of -0.0091 (95% confidence interval [ CI]: -0.0142 to -0.0041), -0.0119 (95% CI: -0.0170 to -0.0068), and -0.0051 (95% CI: -0.0102 to -0.0001)”
Humansmultivariate linear regressionn = 4,033
Biomedical and environmental sciences : BES
Chronic kidney disease
downin humans1OR 0.59
1 study
Chronic kidney disease
downin humans1OR 0.59
Platelet to white blood cell ratio is linked with a lower risk of chronic kidney disease in humans (OR 0.59, 95% CI 0.46-0.76).
“In the full model, the odds ratios (ORs) of prevalent CKD were 0.78 (95% CI = 0.62-0.97, p < 0.05) for the T2 group and 0.59 (95% CI = 0.46-0.76, p < 0.001) for the T3 group.”
Humans
Journal of clinical medicine
Sarcopenia
upin humans1OR 1.57
1 study
Sarcopenia
upin humans1OR 1.57
Platelet to white blood cell ratio is associated with sarcopenia in humans (OR 1.57, 95% CI 1.03–2.40).
“This association remained significant in the fully adjusted model [OR (95%CI) =1.82 (1.20 to 2.78), p-value =0.005 for PLT; OR (95%CI) =1.57 (1.03 to 2.40), p-value =0.035 for PWR].”
Humans
BMC geriatrics
Hemorrhagic stroke
downin humans1
1 study
Hemorrhagic stroke
downin humans1
Platelet to white blood cell ratio is linked with a lower risk of hemorrhagic stroke in humans (increase of 20% for PWR) (aHR = 0.47, 95% CI 0.22–0.95).
“significant associations were observed in those with an increase of 20% for the PWR with the risk of fatal haemarragic stroke (aHR = 0.47, 95% CI 0.22–0.95)”
Humansincrease of 20% for PWRn = 27,811
Research SquarePreprint
Stroke mortality
downin humans1
1 study
Stroke mortality
downin humans1
Platelet to white blood cell ratio is linked with a lower risk of stroke mortality in humans (aHR = 0.73, 95% CI 0.53-1.00).
“A decreased risk of fatal all stroke showed in those with the highest quartiles for both the PWR (aHR = 0.73, 95% CI 0.53-1.00)”
Humansn = 27,811
Research SquarePreprint